insulin degludec / liraglutide Pen Injector [Xultophy]
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Xultophy® (IDegLira) is a fixed ratio combination of basal insulin degludec and glucagon-like peptide-1 (GLP-1) receptor agonist…
Insulin degludec/liraglutide (Xultophy®), a fixed-ratio combination of an ultra-long-acting insulin analogue and a glucagon-like…